Heranba Industries Limited HERANBA NSEINFRA
Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, and bifenthrin. The company also provides fungicides comprising tricyclazole, hexaconazole, tebuconazole, thifluzamide, propiconazole, picoxystrobin, and dodine; herbicides consisting of bispyribac sodium, clodinafop, tembotorine, and pendimethalin; and plant growth regulators. In addition, it offers formulations, such as emulsifiable concentrate, capsule suspension, suspension concentrate, oil dispersion, concentrated aqueous emulsions, wettable powder, suspoemulsion, water dispersible granule, ZC formulation, soluble liquid, flowable concentration, and soluble powder. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
No notable strengths flagged.
CONS
- Revenue declined at -0.8% CAGR over 5 years.
- Earnings shrank at -74.7% CAGR over 5 years.
- Trading 54.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HERANBA Heranba Industries Limited NSEINFRA | 177.90 | - | ₹711.84 Cr | 0.56% | 4.66% | -9.58% | -0.76% | -74.68% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,482.00 | 41.32 | ₹3.38 L Cr | 0.67% | 11.90% | 10.59% | 12.40% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,278.00 | 14.01 | ₹3.12 L Cr | 0.56% | 19.15% | 27.26% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 632.95 | 19.34 | ₹2.67 L Cr | 3.32% | 62.35% | 76.94% | 5.61% | 9.58% |
| 5 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 208.02 | 28.34 | ₹2.59 L Cr | 1.92% | 11.32% | 11.16% | -1.59% | 7.21% |
| 6 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,126.70 | 18.73 | ₹2.52 L Cr | 0.44% | 9.50% | 10.29% | 7.40% | 9.87% |
| 7 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,122.40 | 42.74 | ₹2.12 L Cr | 0.32% | 4.00% | 6.29% | 14.63% | -10.06% |
| 8 | SOLARINDS Solar Industries India Limited NSEINFRA | 18,247.00 | 98.04 | ₹1.65 L Cr | 0.06% | 29.51% | 31.33% | 13.27% | 30.36% |
| 9 | PIDILITIND Pidilite Industries Limited NSEINFRA | 1,482.80 | 61.73 | ₹1.51 L Cr | 0.67% | 28.48% | 23.52% | 7.50% | 24.36% |
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | 341.29 Cr | 327.32 Cr | 452.43 Cr | 521.71 Cr | 301.37 Cr |
| Cost of Revenue | - | 237.50 Cr | 281.09 Cr | 317.13 Cr | 342.33 Cr | 191.95 Cr |
| Gross Profit | - | 103.79 Cr | 46.23 Cr | 135.30 Cr | 179.38 Cr | 109.42 Cr |
| Operating Expenses | - | 105.29 Cr | 76.24 Cr | 125.40 Cr | 156.19 Cr | 122.66 Cr |
| Operating Income | - | -1.50 Cr | -30.01 Cr | 9.90 Cr | 23.19 Cr | -13.24 Cr |
| EBITDA | - | 12.80 Cr | -15.83 Cr | 44.01 Cr | 45.72 Cr | 16.23 Cr |
| Interest Expense | - | 6.15 Cr | 9.73 Cr | 11.55 Cr | 12.33 Cr | 12.39 Cr |
| Pretax Income | - | -7.38 Cr | -41.14 Cr | 11.12 Cr | 7.74 Cr | -21.83 Cr |
| Tax Provision | - | 2.99 Cr | 53.00 L | 4.80 Cr | 9.88 Cr | 1.61 Cr |
| Net Income | - | -10.19 Cr | -40.85 Cr | 6.10 Cr | -1.45 Cr | -23.25 Cr |
| Diluted EPS | 9.49 | -2.55 | - | 1.53 | -0.36 | -5.81 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 1,434.92 Cr | 1,311.25 Cr | 1,248.57 Cr | 1,402.28 Cr |
| Cost of Revenue | 951.50 Cr | 907.14 Cr | 898.55 Cr | 983.40 Cr |
| Gross Profit | 483.42 Cr | 404.11 Cr | 350.02 Cr | 418.88 Cr |
| Operating Expenses | 243.17 Cr | 269.82 Cr | 298.37 Cr | 377.52 Cr |
| Operating Income | 240.25 Cr | 134.29 Cr | 51.65 Cr | 41.36 Cr |
| EBITDA | 279.11 Cr | 166.71 Cr | 88.67 Cr | 101.04 Cr |
| Interest Expense | 4.08 Cr | 6.40 Cr | 10.32 Cr | 26.37 Cr |
| Pretax Income | 255.25 Cr | 137.58 Cr | 52.24 Cr | 18.06 Cr |
| Tax Provision | 66.19 Cr | 33.21 Cr | 17.74 Cr | 15.81 Cr |
| Net Income | 189.06 Cr | 104.37 Cr | 34.89 Cr | 3.07 Cr |
| Diluted EPS | 47.25 | 26.08 | 8.72 | 0.77 |
Compounded Sales Growth
| 5 Years: | -0.76% |
| 1 Year: | -6.20% |
Compounded Profit Growth
| 5 Years: | -74.68% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -40.50% |
| 6 Months: | -29.29% |
| 3 Months: | -14.89% |
| 1 Month: | -20.25% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 1,068.63 Cr | 1,162.28 Cr | 1,481.26 Cr | 1,812.85 Cr |
| Current Assets | 838.68 Cr | 844.16 Cr | 840.48 Cr | 1,032.54 Cr |
| Cash & Equivalents | 95.00 Cr | 100.06 Cr | 28.50 Cr | 42.46 Cr |
| Inventory | 255.74 Cr | 303.59 Cr | 274.72 Cr | 337.39 Cr |
| Receivables | 409.64 Cr | 386.18 Cr | 466.88 Cr | 554.93 Cr |
| Total Liabilities | 354.17 Cr | 351.91 Cr | 628.20 Cr | 962.92 Cr |
| Current Liabilities | 338.59 Cr | 339.41 Cr | 599.03 Cr | 859.58 Cr |
| Long Term Debt | 0 | 0 | 17.91 Cr | 92.69 Cr |
| Total Debt | 53.96 Cr | 93.00 Cr | 164.96 Cr | 348.92 Cr |
| Total Equity | 714.46 Cr | 810.37 Cr | 843.06 Cr | 840.80 Cr |
| Shares Outstanding | 4.00 Cr | 4.00 Cr | 4.00 Cr | 4.00 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 98.11 Cr | 122.50 Cr | 107.20 Cr | 101.30 Cr |
| Investing Cash Flow | -81.72 Cr | -100.06 Cr | -240.91 Cr | -238.87 Cr |
| Financing Cash Flow | -16.27 Cr | -18.08 Cr | 62.02 Cr | 151.66 Cr |
| Capital Expenditure | -80.56 Cr | -61.31 Cr | -253.52 Cr | -275.97 Cr |
| Free Cash Flow | 17.55 Cr | 61.19 Cr | -146.32 Cr | -174.67 Cr |
| Net Change in Cash | 12.00 L | 4.36 Cr | -71.69 Cr | 14.09 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 33.7% | 30.8% | 28.0% | 29.9% |
| Operating Margin % | 16.7% | 10.2% | 4.1% | 2.9% |
| Net Margin % | 13.2% | 8.0% | 2.8% | 0.2% |
| ROE % | 26.5% | 12.9% | 4.1% | 0.4% |
| ROCE % | 32.9% | 16.3% | 5.9% | 4.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HERANBA